Search research articles
Contact Us
Filters
Showing results (231-240 of 266) with videos related to
Page
of 27
Sort By:
Archives of Neurology
|
November 1, 1992
Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease. Pathophysiologic implications
G S Smith, M J de Leon, A E George, et al.
AJNR. American Journal of Neuroradiology
|
July 1, 1993
The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation
M J de Leon, J Golomb, A E George, et al.
The Journal of Nutrition, Health & Aging
|
March 21, 2009
Lessons learned in the use of volumetric MRI in therapeutic trials in Alzheimer's disease: the ALZHEMED (Tramiprosate) experience
D Saumier, P S Aisen, S Gauthier, et al.
Alzheimer Disease and Associated Disorders
|
January 1, 1997
Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study
R C Mohs, D Knopman, R C Petersen, et al.
Alzheimer Disease and Associated Disorders
|
January 1, 1997
The severe impairment battery: concurrent validity and the assessment of longitudinal change in Alzheimer's disease. The Alzheimer's Disease Cooperative Study
F A Schmitt, W Ashford, C Ernesto, et al.
AJNR. American Journal of Neuroradiology
|
May 1, 1983
Regional correlation of PET and CT in senile dementia of the Alzheimer type
M J de Leon, A E George, S H Ferris, et al.
Learning & Memory (Cold Spring Harbor, N.Y.)
|
May 1, 1994
Hippocampal formation size in normal human aging: a correlate of delayed secondary memory performance
J Golomb, A Kluger, M J de Leon, et al.
Current Alzheimer Research
|
February 22, 2008
Rofecoxib in patients with mild cognitive impairment: further analyses of data from a randomized, double-blind, trial
Paul S Aisen, Leon J Thal, Steven H Ferris, et al.
The American Journal of Psychiatry
|
March 1, 1982
18F-2-deoxy-2-fluoro-D-glucose as a tracer in the positron emission tomographic study of senile dementia
T Farkas, S H Ferris, A P Wolf, et al.
International Psychogeriatrics
|
January 1, 1996
Mortality and temporal course of probable Alzheimer's disease: a 5-year prospective study
B Reisberg, S H Ferris, E H Franssen, et al.
Page
of 27
Search research articles
Search
Showing results (231-240 of 266) with videos related to
Sort By:
Page
of 27
Archives of Neurology
|
November 1, 1992
Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease. Pathophysiologic implications
G S Smith, M J de Leon, A E George, et al.
AJNR. American Journal of Neuroradiology
|
July 1, 1993
The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation
M J de Leon, J Golomb, A E George, et al.
The Journal of Nutrition, Health & Aging
|
March 21, 2009
Lessons learned in the use of volumetric MRI in therapeutic trials in Alzheimer's disease: the ALZHEMED (Tramiprosate) experience
D Saumier, P S Aisen, S Gauthier, et al.
Alzheimer Disease and Associated Disorders
|
January 1, 1997
Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study
R C Mohs, D Knopman, R C Petersen, et al.
Alzheimer Disease and Associated Disorders
|
January 1, 1997
The severe impairment battery: concurrent validity and the assessment of longitudinal change in Alzheimer's disease. The Alzheimer's Disease Cooperative Study
F A Schmitt, W Ashford, C Ernesto, et al.
AJNR. American Journal of Neuroradiology
|
May 1, 1983
Regional correlation of PET and CT in senile dementia of the Alzheimer type
M J de Leon, A E George, S H Ferris, et al.
Learning & Memory (Cold Spring Harbor, N.Y.)
|
May 1, 1994
Hippocampal formation size in normal human aging: a correlate of delayed secondary memory performance
J Golomb, A Kluger, M J de Leon, et al.
Current Alzheimer Research
|
February 22, 2008
Rofecoxib in patients with mild cognitive impairment: further analyses of data from a randomized, double-blind, trial
Paul S Aisen, Leon J Thal, Steven H Ferris, et al.
The American Journal of Psychiatry
|
March 1, 1982
18F-2-deoxy-2-fluoro-D-glucose as a tracer in the positron emission tomographic study of senile dementia
T Farkas, S H Ferris, A P Wolf, et al.
International Psychogeriatrics
|
January 1, 1996
Mortality and temporal course of probable Alzheimer's disease: a 5-year prospective study
B Reisberg, S H Ferris, E H Franssen, et al.
Page
of 27